A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology

A composition and low-grade fever technology, applied in the direction of drug combination, antipyretics, pharmaceutical formulas, etc., can solve the problems of long treatment cycle, achieve short treatment time, improve treatment effect, and significant curative effect

Inactive Publication Date: 2021-01-05
孟庆霞
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Chinese patent application publication numbers: CN 104922426A and CN 105497439A each disclose a pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology. Coincidentally, the pharmaceutical compositions proposed by them are all composed of various Chinese medicinal materials, and It has been proved by experiments that both have certain curative effect on postoperative hypothermia in obstetrics and gynecology. The treatment cycle of the two usually takes 40 days, and the basic cure rate is only 30%. Compared with the traditional western medicine treatment, the treatment cycle is too long. long

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology proposed by the present invention includes the following raw materials in parts by weight: 0.2 parts of indomethacin, 8 parts of honeysuckle, 12 parts of dandelion, 15 parts of Folium Isatidis, and 5 parts of Bupleurum. Scrophulariaceae 5, Jujube 13, Lycium barbarum 13, Asparagus 8, Ligustrum lucidum 5, Sophora flavescens 4, Ziheche 5, Polygonatum 8, Cordyceps 1.5.

[0020] Its preparation method comprises the following steps:

[0021] S1. According to 0.2 parts of indomethacin, 8 parts of honeysuckle, 12 parts of dandelion, 15 parts of Daqingye, 5 parts of Bupleurum, 5 parts of Scrophulariaceae, 13 parts of jujube, 13 parts of medlar, 8 parts of asparagus, female 5 parts of Zhenzi, 4 parts of Sophora flavescens, 5 parts of Ziheche, 8 parts of Polygonatum, 1.5 parts of Cordyceps sinensis Weigh each raw material and set aside;

[0022] S2. Put the honeysuckle, dandelion, Fol...

Embodiment 2

[0028] A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology proposed by the present invention comprises the following raw materials in parts by weight: 0.2 parts of indomethacin, 6 parts of honeysuckle, 12 parts of dandelion, 14 parts of Folium Isatidis, and 5 parts of Bupleurum 5 parts of Scrophulariaceae, 12 parts of Jujube, 14 parts of Lycium barbarum, 8 parts of Asparagus, 6 parts of Ligustrum lucidum, 4 parts of Sophora flavescens, 6 parts of Ziheche, 8 parts of Polygonatum, and 2 parts of Cordyceps sinensis.

[0029] Its preparation method comprises the following steps:

[0030] S1. According to 0.2 parts of indomethacin, 6 parts of honeysuckle, 12 parts of dandelion, 14 parts of Daqingye, 5 parts of Bupleurum, 5 parts of Scrophulariaceae, 12 parts of jujube, 14 parts of medlar, 8 parts of asparagus, female 6 parts of Zhenzi, 4 parts of Sophora flavescens, 6 parts of Ziheche, 8 parts of Polygonatum, 2 parts of Cordyceps sinensi...

Embodiment 3

[0037] A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology proposed by the present invention comprises the following raw materials in parts by weight: 0.2 parts of indomethacin, 7 parts of honeysuckle, 10 parts of dandelion, 14 parts of Folium Isatidis, and 5 parts of Bupleurum Scrophulariaceae 5 parts, Jujube 12 parts, Lycium barbarum 12 parts, Asparagus 6 parts, Ligustrum lucidum 5 parts, Sophora flavescens 5 parts, Ziheche 4 parts, Polygonatum 8 parts, Cordyceps 1 part.

[0038] Its preparation method comprises the following steps:

[0039]S1. According to 0.2 parts of indomethacin, 7 parts of honeysuckle, 10 parts of dandelion, 14 parts of Daqingye, 5 parts of Bupleurum, 5 parts of Scrophulariaceae, 12 parts of jujube, 12 parts of medlar, 6 parts of asparagus, female 5 parts of Zhenzi, 5 parts of Sophora flavescens, 4 parts of Ziheche, 8 parts of Polygonatum, and 1 part of Cordyceps sinensis Weigh each raw material and set aside...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating low-grade fever after gynecological and obstetrical surgery. The medicine composition comprises, by weight, 0.1-0.3 part of indometacin, 5-10 parts of honeysuckle, 8-16 parts of dandelion, 10-20 parts of folium isatidis, 3-8 parts of radix bupleuri, 3-8 parts of radix scrophulariae, 10-15 parts of fructus ziziphi jujubae, 10-15 parts of fructus lycii, 5-10 parts of radix asparagi, 3-8 parts of fructus ligustri lucidi, 2-6 parts of radix sophorae flavescentis, 3-8 parts of placenta hominis, 5-10 parts of rhizoma polygonati and 0.5-2.5parts of cordyceps sinensis. The medicine composition has efficacy of diminishing inflammation to relieve pain, clearing heat for detoxification, nourishing yin to decrease internal heat, moistening dryness to promote salivation, activating blood to remove blood stasis, tonifying qi to enrich blood, nourishing body and improving immunity and is remarkable in treatment effect on low-grade fever after the gynecological and obstetrical surgery, short in treatment time, low in dependence and low in treatment cost.

Description

technical field [0001] The invention relates to the technical field of drug research and development, in particular to a pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology. Background technique [0002] Postoperative hypothermia in obstetrics and gynecology is one of the common symptoms after obstetrics and gynecology surgery. Its clinical manifestations are dizziness, palpitations, cough, fatigue, loss of appetite, etc., mostly due to decreased immunity of patients after surgery, or inflammation such as rheumatism and tuberculosis And cause, eventually lead to the disease that the body temperature nerve center is disordered or damaged. The current clinical treatment measures are usually antibiotics, such as penicillin and second-generation cephalosporins, but the cost of antibiotics is relatively high, and long-term use will lead to drug dependence. Therefore, more and more researchers are turning to the combination of Chinese an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8969A61P15/00A61P29/00A61K35/50A61K31/405
CPCA61K31/405A61K35/50A61K36/068A61K36/195A61K36/233A61K36/288A61K36/315A61K36/355A61K36/489A61K36/638A61K36/704A61K36/725A61K36/808A61K36/815A61K36/855A61K36/8965A61K36/8969A61K2236/33A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2300/00
Inventor 孟庆霞李海莉苏丽丽邢鲁彦张倩
Owner 孟庆霞
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap